Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v2.4.0.6
Consolidated Balance Sheets (USD $)
Mar. 31, 2013
Dec. 31, 2012
Current assets:    
Cash and cash equivalents $ 680,676 $ 1,572,785
Short-term investments 182,061 181,859
Accounts receivable, net 3,015,992 2,700,243
Inventory, net 3,405,699 3,356,622
Costs in excess of billing 354,625 0
Due from related party 0 55,837
Prepaid and other current assets 310,043 402,846
Total current assets 7,949,096 8,270,192
Property, plant and equipment, net 702,950 435,612
Intangible assets, net 685,218 372,020
Other assets 39,425 39,425
TOTAL ASSETS 9,376,689 9,117,249
Current liabilities:    
Demand notes payable, related party 1,337,500 1,337,500
Current portion of convertible debentures, related party 90,967 90,967
Accounts payable 1,461,908 1,151,010
Accrued expenses 1,006,540 807,922
Deferred revenue 561,539 677,919
Due to related party 760,535 0
Interest payable, related party 146,972 126,170
Total current liabilities 5,365,961 4,191,488
Long-term liabilities:    
Deferred revenue, net of current portion 148,595 142,726
Total liabilities 5,514,556 4,334,214
Commitments and contingencies (Note 5) 0 0
Tecogen Inc. shareholders’ equity:    
Common stock, $0.001 par value; 100,000,000 shares authorized; 54,447,854 issued and outstanding at March 31, 2013 and December 31, 2012 54,448 54,448
Additional paid-in capital 16,373,090 16,319,985
Accumulated deficit (12,620,116) (11,759,723)
Total Tecogen Inc. stockholders’ equity 3,807,422 4,614,710
Noncontrolling interest 54,711 168,325
Total stockholders’ equity 3,862,133 4,783,035
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 9,376,689 $ 9,117,249